ICCM
Icecure MedicalNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$19.09M
P/E Ratio
—
EPS
$-0.24
Beta
1.63
52W High
$1.40
52W Low
$0.21
50-Day MA
$0.36
200-Day MA
$0.67
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Icecure Medical
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets. The company is headquartered in Caesarea, Israel.
Fundamentals
| Revenue (TTM) | $3.56M |
| Gross Profit (TTM) | $1.30M |
| EBITDA | $-15.41M |
| Operating Margin | -466.20% |
| Return on Equity | -217.20% |
| Return on Assets | -80.30% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $0.12 |
| Price-to-Book | 2.25 |
| Price-to-Sales (TTM) | 5.36 |
| EV/Revenue | 3.118 |
| EV/EBITDA | -2.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 25.70% |
| Shares Outstanding | $81.24M |
| Float | $44.30M |
| % Insiders | 41.40% |
| % Institutions | 4.00% |
Analyst Ratings
Consensus ($1.48 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026